Author: Oba, Jane; de Carvalho, Werther Brunow; Silva, Clovis Artur; Delgado, Artur Figueiredo
Title: Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians Cord-id: h252cuth Document date: 2020_7_7
ID: h252cuth
Snippet: Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread globally in pandemic proportions. Accumulative evidence suggests SARS-CoV-2 can be transmitted through the digestive system, the so-called fecal-oral route of transmission, and may induce several gastrointestinal manifestations. MEDLINE(®) and Embase databases were extensively searched for major clinical manifestations of gastrointestinal involvement in c
Document: Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread globally in pandemic proportions. Accumulative evidence suggests SARS-CoV-2 can be transmitted through the digestive system, the so-called fecal-oral route of transmission, and may induce several gastrointestinal manifestations. MEDLINE(®) and Embase databases were extensively searched for major clinical manifestations of gastrointestinal involvement in children and adolescents with COVID-19 reported in medical literature, and for nutritional therapy-related data. Findings and recommendations were pragmatically described to facilitate overall pediatric approach. A total of 196 studies addressing gastrointestinal or nutritional aspects associated with the global COVID-19 pandemic were found. Of these, only 17 focused specifically on pediatric patients with regard to aforementioned gastrointestinal or nutritional aspects. Most articles were descriptive and six addressed guidelines, established protocols, or expert opinions. Children and adolescents with gastrointestinal symptoms, such as nausea, vomiting and diarrhea, should be seriously suspected of COVID-19. Gastrointestinal signs and symptoms may occur in 3% to 79% of children, adolescents and adults with COVID-19, and are more common in severe cases. These include diarrhea (2% to 50%), anorexia (40% to 50%), vomiting (4% to 67%), nausea (1% to 30%), abdominal pain (2% to 6%) and gastrointestinal bleeding (4% to 14%). Patients with inflammatory bowel disease or chronic liver disease are not at greater risk of infection by SARS-CoV-2 relative to the general population. Nutritional support plays an important role in treatment of pediatric patients, particularly those with severe or critical forms of the disease. The digestive system may be a potential route of COVID-19 transmission. Further research is needed to determine whether the fecal-oral route may be involved in viral spread. Nutritional therapy is vital to prevent malnutrition and sarcopenia in severe cases.
Search related documents:
Co phrase search for related documents- abdominal pain and active disease: 1, 2, 3, 4, 5
- abdominal pain and active ibd disease: 1
- abdominal pain and acute febrile illness: 1
- abdominal pain and acute respiratory failure: 1, 2, 3, 4, 5, 6
- abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain and adenovirus virus: 1, 2
- active disease and acute respiratory failure: 1, 2, 3, 4
- active disease and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active disease and adalimumab infliximab: 1, 2, 3, 4
- active disease and adenovirus virus: 1, 2
- active disease patient and acute respiratory syndrome: 1, 2, 3
- active ibd disease and acute respiratory syndrome: 1
- active inflammation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- acute febrile illness and adenovirus virus: 1, 2, 3, 4
- acute respiratory failure and adalimumab infliximab: 1
- acute respiratory failure and adenovirus virus: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and adalimumab infliximab: 1, 2, 3, 4, 5
- acute respiratory syndrome and adenovirus virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date